Peptide Pricing in Canada: What You Are Actually Paying For

Cost scales with sequence length and with modifications. A three-residue compound is cheap chemistry: few coupling cycles, high crude yield, straightforward purification. A forty-plus-residue sequence is not, and a lipidated or otherwise modified compound is not, because each modification adds steps, reagents and yield loss. The mechanics are in how peptides are made.

This is what accounts for most of the price differences between compounds rather than between suppliers. A price gap between KPV and cagrilintide is chemistry. A price gap between two suppliers selling the same compound is something else.

Amino Acid Sequence

Amino Acid Sequence

Taking a crude synthesis to research grade costs yield. Preparative HPLC separates the target from deletion sequences and by-products, and the collection window is a direct trade: cut it tightly for higher purity and less product, cut it generously for more product and more impurity.

A supplier that accepts a lower grade keeps the yield it would otherwise have discarded, and keeps the margin with it. Nothing about the vial reveals which choice was made. The certificate does.

Independent per-lot analysis, meaning purity, identity and quantified content, is a real recurring cost charged per lot rather than per year. Skipping it, testing once and reusing the document, or self-certifying are all direct savings, and all three are a transfer of risk from the supplier to the buyer.

This is the cost most easily disguised, because "third-party tested" costs nothing to write. What distinguishes a real testing programme is that the certificates are lot-specific, published before sale and checkable at the laboratory rather than only on the supplier's site.

The quietest cost of all: actually putting the labelled quantity in the vial. Peptide is the dominant input cost, so filling short is the largest available saving with the smallest visible consequence, and it is invisible to the purity figure most buyers check. That is the subject of underfilled vials.

A price meaningfully under market where the certificate does not publish measured content is the most common shape this takes.

A listing 30 to 40% under market is telling you one of the four was skipped, and it is rarely the first. Upstream synthesis chemistry is broadly similar across suppliers buying from a similar base, so the compression usually comes from purification grade, from testing, or from fill.

None of the three is visible at checkout. All three are visible on a complete, externally verifiable certificate, which is why the supplier checklist starts with certificates rather than with prices. The full version is how to choose a peptide supplier in Canada.

Available at Eppix Labs

Buy KPV Peptide Canada | 10mg & 30mg

10mg · 30mg

Every batch tested by an independent laboratory, with the certificate published before sale.

From $50.00 CADIn stock

Available at Eppix Labs

Buy Tesamorelin Canada | 10mg & 20mg

10mg · 20mg

Every batch tested by an independent laboratory, with the certificate published before sale.

From $75.00 CADIn stock

Mid-market, with the testing and the fill documented per lot rather than asserted. Multi-vial packs carry a discount because pack pricing spreads fixed handling and shipping costs rather than because the material differs, and an Interac e-Transfer discount passes back part of the difference in processing cost, which is explained in Interac e-Transfer for research orders.

Where a listing here is not the cheapest available, the certificate is the argument for the difference. That is a claim you can check rather than one you have to accept.